Achieve Life Sciences
ACHV
58 hedge funds and large institutions have $68.7M invested in Achieve Life Sciences in 2013 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 6 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
33% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 12
3% less funds holding
Funds holding: 60 → 58 (-2)
11% less capital invested
Capital invested by funds: $77.5M → $68.7M (-$8.79M)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
100% less call options, than puts
Call options by funds: $6K | Put options by funds: $1.74M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$456K |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$456K |
| 3 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$269K |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$228K |
| 5 |
BBA
BLB&B Advisors
Montgomeryville,
Pennsylvania
|
+$186K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.28M |
| 2 |
JGC
J. Goldman & Co
New York
|
-$1.26M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$932K |
| 4 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
-$648K |
| 5 |
Jane Street
New York
|
-$542K |
ACHV Hedge Fund Activity: Q3 2013 in Review
58 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q3 2013, worth a combined $68.7M — down 11% from $77.5M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of ACHV and 5 opened new positions — a net loss of 1 holder — while 12 trimmed existing stakes and 16 added.
The largest buyer was BlackRock Fund Advisors, adding an estimated $456K. The largest seller was Fidelity Investments, cutting an estimated $2.28M.
- 58 institutional investors held Achieve Life Sciences (ACHV) as of Q3 2013, down from 60 in Q2 2013.
- Funds reported $68.7M of Achieve Life Sciences stock for Q3 2013, down 11% quarter-over-quarter.
- 5 funds opened new Achieve Life Sciences positions in Q3 2013 and 6 closed out, a net change of -1 holder.
- The largest Achieve Life Sciences buyer in Q3 2013 was BlackRock Fund Advisors, an estimated $456K added.
- The largest Achieve Life Sciences seller in Q3 2013 was Fidelity Investments, an estimated $2.28M sold.
Based on aggregated 13F filings for Q3 2013.